Major Events - China Power (02380) plans to acquire a 31% stake in Dazhou Energy [1] - Shun Teng International Holdings (00932) received a 20% discount from Chairman Zhang Shaohui for a full acquisition offer [1] - Huajian Medical (01931) established a joint venture to deepen the global blockchain financial ecosystem strategy through the "ETHK" core brand [1] - Derin Holdings (01709) signed a strategic cooperation and investment agreement with Winner Fashion (03709) [1] - Dongwu Cement (00695) major shareholder Goldview intends to sell a total of 204 million shares, making Hong Kong Aviation the single largest shareholder [1] - CSPC Pharmaceutical Group (01093) received clinical trial approval for SYH2066 tablets in China [1] - GAC Group (02238) plans to issue up to 15 billion yuan in corporate bonds and 15 billion yuan in medium-term notes [1] - Huatai Securities (06886) plans to issue up to 6 billion yuan in corporate bonds [1] - Ark Health (06086) stated that the H2H conference news is not insider information and is unaware of the reason for the stock price increase [1] Financial Data - China Resources Land (01109) reported a cumulative contract sales amount of 136.8 billion yuan for the first eight months, a year-on-year decrease of 12.0% [1] - Yuexiu Property (00123) reported a cumulative contract sales amount of approximately 73.011 billion yuan for the first eight months, a year-on-year increase of approximately 3.7% [1] - Zhong An Online (06060) reported a total original insurance premium income of approximately 23.625 billion yuan for the first eight months, a year-on-year increase of 6.36% [1]

Group 1 - The core transaction involves Leading Virtue Holdings Limited, owned by Zhang Shaohui, acquiring a total of 734,040,033 shares from ProsperRich and Hammer Capital Consulting for a total consideration of 17,616,960 HKD [1][2] - The total shares being sold represent approximately 24.65% of the company's issued share capital, with the price per share set at approximately 0.024 HKD, which is a discount of about 20% compared to the closing price of 0.030 HKD on the date of the announcement [1][2] - Following the completion of the transaction, the offeror and its concert parties will hold 1,516,534,033 shares, representing 48.80% of the total issued shares [2] Group 2 - The offeror intends to continue operating the existing business of the group without significant changes, including not terminating any employees or disposing of fixed assets, while retaining the right to make necessary adjustments to enhance group value [3]

Group 1 - The core transaction involves Leading Virtue acquiring approximately 734 million shares from Prosper Rich and Hammer Capital Consulting for a total consideration of HKD 17.61696 million, with an additional purchase of 32 million shares by Mr. Zhang Shaohui for HKD 0.768 million [1] - The total shares sold amount to approximately 766 million, representing 24.65% of the company's total issued share capital, with a total consideration of HKD 18.38496 million, equating to approximately HKD 0.024 per share [1] - Following the completion of the transaction, the offeror and its concert parties will hold rights to 1,516,534,033 shares, which is 48.80% of the total issued shares [1] Group 2 - The offeror, Mr. Zhang Shaohui, is the sole shareholder and director of Leading Virtue, which primarily engages in investment holding [2] - Mr. Zhang serves as the chairman and executive director of the board [2] Group 3 - According to the takeover code rule 26.1, the offeror is required to make a mandatory conditional cash offer for all issued shares, excluding those already owned or agreed to be acquired by the offeror and its concert parties [1] - The cash offer is set at HKD 0.024 per share, representing a discount of approximately 20.00% compared to the closing price of HKD 0.030 per share on the date of the announcement [1]

Group 1 - The offeror Leading Virtue and Shun Teng International Holdings (00932) announced a share acquisition of approximately 734 million shares from Prosper Rich and Hammer Capital Consulting for a total consideration of 17.61696 million HKD [1] - The shares being sold, totaling approximately 766 million, represent about 24.65% of the company's total issued share capital, with a total sale price of 18.38496 million HKD, equating to approximately 0.024 HKD per share [1] - Following the completion of the transaction, the offeror and its concert parties will hold interests in 1,516,534,033 shares, accounting for 48.80% of the total issued shares [1] Group 2 - According to the takeover code rule 26.1, the offeror is required to make a mandatory conditional cash offer for all issued shares, excluding those already owned or agreed to be acquired by the offeror and its concert parties [1] - The offer will be made at a cash price of 0.024 HKD per share, which represents a discount of approximately 20.00% compared to the closing price of 0.030 HKD per share on the date of the announcement [1] - Mr. Zhang Shaohui is the sole shareholder and director of the offeror, which primarily engages in investment holding [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本聯合公告的內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本聯合公告全 部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 本聯合公告僅供參考，並不構成收購、購買或認購順騰國際（控股）有限公司股份之 邀請或要約。倘於或向任何司法權區發佈、刊發或派發本聯合公告違反該等司法權 區之相關法律，則本聯合公告不得於或向該等司法權區發佈、刊發或派發。 LEADING VIRTUE HOLDINGS LIMITED （於英屬處女群島註冊成立之有限公司） Shunten International (Holdings) Limited 順 騰 國 際（ 控 股 ）有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：932） 聯合公告 (1)有關LEADING VIRTUE HOLDINGS LIMITED及 張少輝收購銷售股份之協議；及 (2)發利證券有限公司 代表LEADING VIRTUE HOLDINGS LIMITED 收購順騰國際（控股）有限公司 全部已發行股份 （要約人及其一致行動人士已擁有及╱或同意將予收購的 ...

Shunten International (Holdings) Limited 順騰國際（控股）有限公司 （於開曼群島註冊成立之有限公司） （股份代號：932） 於二零二五年九月三日舉行的股東週年大會之 一股一票投票結果 順 騰 國 際（控 股）有 限 公 司（「本公司」）董 事 會（「董事會」）欣 然 宣 佈，本 公 司 於 二 零 二 五 年 九 月 三 日 舉 行 的 股 東 週 年 大 會（「股東週年大會」）上 所 有 提 呈 之 決 議 案 已 正 式 通 過。 謹 提 述 本 公 司 日 期 均 為 二 零 二 五 年 七 月 二 十 五 日 之 通 函（「該通函」）及 股 東 週 年 大 會 通 告（「通 告」），當 中 載 有 在 股 東 週 年 大 會 提 呈 的 決 議 案 詳 情。 除本公告另有界定者外，本公告所用詞彙與該通函所界定者具相同涵義。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 會對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 順騰國際(控股)有限公司 呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00932 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 4,000,000,000 | HKD | | 0.0025 | HKD | | 10,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 4,000,000,000 | HKD | | 0.0025 | HKD | | 10,000,000 | 本月底法 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 Shunten International (Holdings) Limited 順騰國際（控股）有限公司 （於開曼群島註冊成立之有限公司） （股份代號：932） 補充公告 須予披露交易 直 接 比 較 法 假 設 物 業 以 其 現 狀 出 售 且 具 備 空 置 交 付 的 條 件，同 時 參 考 相 關市場中的可比 較 銷 售 交 易。估 值 師 認 為 直 接 比 較 法 為 對 該 物 業 進 行 估 值 的 最 適 當 估 值 方 法，該 物 業 為 香 港 的 標 準 住 宅 物 業。本 地住宅市場的 活 躍 度 高 且 透 明 度 高，其 特 點 是 具 有 豐 富、適 時 且 可 公 開 獲 取 的 交 易 憑 證，因 而 形 成 廣 泛 且 可 靠 的 可 比 較 交 易 範 圍。該 可 取性使得直接比較法 的應用 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 公司名稱: 順騰國際(控股)有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00932 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 4,000,000,000 | HKD | | 0.0025 | HKD | | 10,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 4,000,000,000 | HKD | | 0.0025 | HKD | | 10,000,000 | 本月底法定/註冊股本總額： HKD 10,000,000 FF301 第 1 頁 共 1 ...

Company Overview - Shun Teng International Holdings Limited is a publicly listed company in Hong Kong, previously known as Yu Yao Tang Group Holdings Limited, and has been listed on the Hong Kong Stock Exchange since October 11, 2013 [3] - The company primarily engages in the sales, marketing, and distribution of health and beauty supplements and products in Hong Kong and China [3] Financial Performance - As of March 31, 2025, Shun Teng International reported total revenue of 189 million yuan, a year-on-year decrease of 12.96% [2] - The company recorded a net profit attributable to shareholders of -33.4461 million yuan, representing a significant year-on-year decline of 6447.29% [2] - The gross profit margin stood at 77.03%, while the debt-to-asset ratio was 53.15% [2] Stock Performance - As of July 28, the stock price of Shun Teng International closed at 0.032 HKD per share, reflecting an increase of 10.34% with a trading volume of 732,000 shares and a turnover of 23,100 HKD [1] - Over the past month, the stock has experienced a cumulative decline of 9.38%, and since the beginning of the year, it has decreased by 6.45%, underperforming the Hang Seng Index, which has risen by 26.56% [2] Industry Valuation - The average price-to-earnings (P/E) ratio for the pharmaceutical and biotechnology industry is 3.12 times, with a median of 6.67 times [2] - Shun Teng International's P/E ratio is -2.49 times, ranking 146th in the industry [2] - Comparatively, other companies in the industry have the following P/E ratios: Other Precision Pharmaceuticals at 1.27 times, Kingsray Biotechnology at 1.69 times, Dongrui Pharmaceutical at 3.35 times, Jilin Changlong Pharmaceutical at 6.39 times, and Dajian Health International at 6.67 times [2]